NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceLenvatinib withpembrolizumab foruntreated advanced renalcell carcinomaTechnology appraisal guidancePublished:11 January 2023www.nice.org.uk/quidance/ta858NICE 2023.All rights reserved.Subject to Notice of rights (https://www.nice.org.uk/temms-and-conditions#notice-of-rights).